Mucormycosis — A New Risk of Deferoxamine Therapy in Dialysis Patients with Aluminum or Iron Overload?

2 July 1987

journal article
Published by Massachusetts Medical Society in New England Journal of Medicine

Vol. 317 (1) , 54
https://doi.org/10.1056/nejm198707023170114

Abstract

Correspondence from The New England Journal of Medicine — Mucormycosis — A New Risk of Deferoxamine Therapy in Dialysis Patients with Aluminum or Iron Overload?

Keywords

This publication has 7 references indexed in Scilit:

Myocardial Mucormycosis With Emboli in a Hemodialysis Patient
American Journal of Kidney Diseases, 1986
REPLY
Australian and New Zealand Journal of Medicine, 1985
EFFECT OF AN IRON‐CHELATING AGENT ON LYMPHOCYTE PROLIFERATION
Immunology & Cell Biology, 1984
Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation
Blood, 1984
DESFERRIOXAMINE AND SYSTEMIC YERSINIOSIS
The Lancet, 1983
Host Defenses and Infectious Complications in Maintenance Hemodialysis Patients
Published by Springer Nature ,1983
Mucormycotic slough of nasal floor and palate in the anephric patient
The Journal of the American Dental Association, 1979